The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $145.76

Today's change0.00 0.00%
Updated January 12 4:00 PM EST. Delayed by at least 15 minutes.
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $145.76

Today's change0.00 0.00%
Updated January 12 4:00 PM EST. Delayed by at least 15 minutes.

Johnson & Johnson closed at (U.S.)$145.76.

Over the last five days, shares have gained 2.86% and outperformed the S&P 500 index over the last 52 weeks with a 27.17% increase in price.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $145.76
  • High--
  • Low--
  • Bid / Ask(U.S.) $146.05 / (U.S.) $146.45
  • YTD % change+4.32%
  • Volume3,401
  • Average volume (10-day)5,556,823
  • Average volume (1-month)5,903,352
  • Average volume (3-month)5,474,609
  • 52-week range(U.S.) $110.76 to (U.S.) $146.42
  • Beta0.80
  • Trailing P/E25.33×
  • P/E 1 year forward20.02×
  • Forward PEG2.81×
  • Indicated annual dividend(U.S.) $3.36
  • Dividend yield2.31%
  • Trailing EPS(U.S.) $5.76
Updated January 12 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 01, 201710/01/2017Jul 02, 201707/02/2017Apr 02, 201704/02/2017Jan 01, 201701/01/2017
Revenue19,65018,83917,76618,106
Total other revenue--------
Total revenue19,65018,83917,76618,106
Gross profit12,77713,02912,38412,590
Total cost of revenue6,8735,8105,3825,516
Total operating expense14,86014,09112,19113,782
Selling / general / administrative5,3965,2624,7375,309
Research & development2,5732,2862,0652,640
Depreciation / amortization--------
Interest expense (income), net operating229227204184
Unusual expense (income)187128161298
Other operating expenses, total-337546-260-110
Operating income4,7904,7485,5754,324
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax4,7904,7485,5754,324
Income after tax3,7643,8274,4223,814
Income tax, total1,0269211,153510
Net income3,7643,8274,4223,814
Total adjustments to net income--------
Net income before extra. items3,7643,8274,4223,814
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,7643,8274,4223,814
Inc. avail. to common incl. extra. items3,7643,8274,4223,814
Diluted net income3,7643,8274,4223,814
Dilution adjustment--------
Diluted weighted average shares2,7382,7422,7552,766
Diluted EPS excluding extraordinary itemsvalue per share1.371.401.611.38
Dividends per sharevalue per share0.840.840.800.80
Diluted normalized EPSvalue per share1.571.671.651.50